publication venue for
- The Black Book of Psychotropic Dosing and Monitoring.. 48. 2018
- Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study.. 42. 2009
- REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design.. 41. 2008
- Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.. 37. 2003
- Duloxetine for the treatment of major depressive disorder.. 36. 2002
- A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale.. 33. 1997
- The role of estrogen in late-life depression: opportunities and barriers to research.. 33. 1997
- An open study of buspirone augmentation of serotonin-reuptake inhibitors in body dysmorphic disorder.. 32. 1996
- Gender differences in presentation of chronic major depression.. 31. 1995
- Skin picking as a symptom of body dysmorphic disorder.. 31. 1995
- Stability of remission during tricyclic antidepressant continuation therapy for dysthymia.. 31. 1995
- Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community.. 31. 1995
- A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases.. 30. 1994
- Effects of nortriptyline on memory self-assessment and performance in recovered elderly depressives.. 27. 1991
- Serotonergic responsivity in eating disorders.. 27. 1991
- Verbal memory and plasma drug concentrations in elderly depressives treated with nortriptyline.. 27. 1991
- Open assessment of the safety and efficacy of thioridazine in the treatment of patients with borderline personality disorder.. 25. 1989
- Aminergic receptor binding correlates of suicide: methodological issues.. 22. 1986
- Chronic depression: demographic and clinical characteristics.. 22. 1986
- Postmortem serotonergic and adrenergic receptor binding to frontal cortex: correlations with suicide.. 22. 1986
- Suicide and adrenocortical function.. 22. 1986
- Depression, hypothalamic-pituitary-adrenocortical activity, and lymphocyte function.. 21. 1985
- Imipramine for treatment of chronic depression.. 21. 1985
- Nocturnal serum melatonin in major depressive disorder before and after desmethylimipramine treatment.. 21. 1985
- Dexamethasone elevates dopamine in human plasma and rat brain.. 20. 1984
- The DST in psychotic depression: diagnostic and pathophysiologic implications.. 20. 1984
- Diagnostic assessments and relationships of outcome [proceedings].. 17. 1981
- Possible pathophysiological mechanisms in subtypes of unipolar depressive disorders based on differences in urinary MHPG levels [proceedings].. 17. 1981
- Phencyclidine (PCP) and derivatives: pharmacology and structure-activity relationships [proceedings].. 16. 1980
- Histamine and psychotropic drugs.. 16. 1980
- Diagnosis and treatment of depression in late life: the NIH Consensus Development Conference Statement. 1993
- Personality disorders: issues in assessment. 1989
- Depression in the elderly. 2002
- Outcomes for antidepressant trials in late-life depression. 1997
- Neurochemical studies of violent and nonviolent suicide. 1989
- Rates of change of common measures of impairment in senile dementia of the Alzheimer's type. 1988